NASDAQ:XGN
Exagen Inc.
Exagen Inc.'s revenue grew 19.7% in fiscal 2025 to $66.6M while operating margin rose to −21.1%. Free cash flow was −$14.3M, −21.4% of revenue, and the diluted share count rose 18.4%.Summary generated from Exagen Inc.'s SEC filings. Latest annual report filed Mar 10, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$66.6M
Revenue growth+19.7%
Revenue, 5-yr CAGR+9.7%
Gross margin58.3%
Operating margin−21.1%
Net margin−30.0%
ROIC−139.9%
Return on equity−147.8%
Debt / equity1.31
Free cash flow−$14.3M
FCF margin−21.4%
Share count change+18.4%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 48 | 46 | 53 | 56 | 67 |
| Operating income | −24 | −46 | −23 | −14 | −14 |
| Net income | −27 | −47 | −24 | −15 | −20 |
| Free cash flow | −23 | −36 | −15 | −14 | −14 |
Recent filings
- 4Insider transaction report
Sep 2, 2026 - 4Insider transaction report
Aug 19, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 4, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KResults of a shareholder vote
Jun 9, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 11, 2026 - 8-KResults of operations and financial condition
May 11, 2026 - DEF 14AProxy statement
Apr 27, 2026